Understanding how early brain development affects cognitive speed in mice with genetic disorders

Identifying a critical developmental period for cognitive speed in a mouse model for neurodevelopmental disorders

NIH-funded research University of Texas Hlth Science Center · NIH-11067729

This study is looking at how a gene called TBX1 affects brain development and thinking skills in mice, which could help us understand how similar issues might impact brain development and learning in people.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center NIH-funded
Lab location1 site (San Antonio, United States)
Project IDNIH-11067729 on NIH RePORTER

What this research studies

This research investigates the role of a specific gene, TBX1, in the early development of the brain and its impact on cognitive abilities in mice. By studying mice with a genetic deletion associated with neurodevelopmental disorders, the researchers aim to identify critical periods during which brain development influences cognitive speed. The approach involves manipulating gene expression during specific developmental stages and assessing the resulting cognitive performance in tasks related to attention and memory. This could provide insights into how similar processes might affect human cognitive development.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals under 21 years old with conditions related to the 22q11.2 deletion syndrome or similar neurodevelopmental disorders.

Not a fit: Patients who do not have neurodevelopmental disorders or are over 21 years old may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and potential interventions for cognitive impairments associated with neurodevelopmental disorders in humans.

How similar studies have performed: Previous research has shown that understanding genetic influences on brain development can lead to significant advancements in treating cognitive impairments, suggesting this approach has potential for success.

Where this research is happening

San Antonio, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions 22q11 Chromosomal Microdeletion Syndrome22q11 Deletion Syndrome22q11.2 deletion syndrome
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.